Jane Street Group LLC Raises Position in Henry Schein, Inc. (HSIC)

Jane Street Group LLC increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 244.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,894 shares of the company’s stock after acquiring an additional 7,024 shares during the quarter. Jane Street Group LLC’s holdings in Henry Schein were worth $811,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of HSIC. Candriam Luxembourg S.C.A. boosted its position in shares of Henry Schein by 50.5% during the second quarter. Candriam Luxembourg S.C.A. now owns 1,830 shares of the company’s stock worth $335,000 after acquiring an additional 614 shares during the last quarter. Beach Investment Management LLC. bought a new position in Henry Schein during the second quarter valued at $2,625,000. Global X Management Co. LLC lifted its position in Henry Schein by 13.4% during the second quarter. Global X Management Co. LLC now owns 1,580 shares of the company’s stock valued at $289,000 after purchasing an additional 187 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its position in Henry Schein by 3.9% during the second quarter. Schwab Charles Investment Management Inc. now owns 274,419 shares of the company’s stock valued at $50,225,000 after purchasing an additional 10,181 shares during the last quarter. Finally, First Trust Advisors LP lifted its position in Henry Schein by 45.9% during the second quarter. First Trust Advisors LP now owns 124,236 shares of the company’s stock valued at $22,738,000 after purchasing an additional 39,105 shares during the last quarter. Hedge funds and other institutional investors own 91.75% of the company’s stock.

In other news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.19% of the company’s stock.

Several equities analysts have commented on HSIC shares. Credit Suisse Group reiterated a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Piper Jaffray Companies upgraded shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Craig Hallum upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Zacks Investment Research lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, November 13th. Finally, Morgan Stanley started coverage on shares of Henry Schein in a research report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price objective for the company. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $87.79.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at $68.70 on Thursday. Henry Schein, Inc. has a 12 month low of $65.28 and a 12 month high of $93.50. The firm has a market cap of $10,723.13, a price-to-earnings ratio of 19.16, a PEG ratio of 1.92 and a beta of 0.99. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm had revenue of $3.16 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period in the prior year, the company posted $0.84 EPS. The company’s revenue was up 10.3% compared to the same quarter last year. sell-side analysts expect that Henry Schein, Inc. will post 3.6 EPS for the current year.

Henry Schein announced that its Board of Directors has authorized a stock buyback plan on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: “Jane Street Group LLC Raises Position in Henry Schein, Inc. (HSIC)” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://ledgergazette.com/2017/12/14/jane-street-group-llc-raises-position-in-henry-schein-inc-hsic.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply